An investigation into the pharmaceutical advertising in Iranian medical journals

References

• LeeB,SalmonCT,PaekH-J. The effects of information sources on consumer reactions to direct-to-consumer (DTC) prescription drug advertising: a consumer socialization approach. J Advert. 2007;36:107–119.
   Web of Science ®Google Scholar
• HELPDESK. Pharmaceutical Industry In Iran [Internet]. https://sanctions-helpdesk.eu/sites/default/files/2021-04/2020.10.ThePharmaceuticalIndustryinIran_0.pdf (2020) Accessed 9 Oct 2021.
   Google Scholar
• AlvesTL,LexchinJ,MintzesB. Medicines information and the regulation of the promotion of pharmaceuticals. Sci Eng Ethics. 2019;25:1167–1192.
   PubMed Web of Science ®Google Scholar
• HefflerS,LevitK,SmithS,SmithC,CowanC,LazenbyH.et al. Health spending growth up in 1999; faster growth expected in the future. Health Aff. 2001;20:193–203.
   Web of Science ®Google Scholar
• WilkesMS,BellRA,KravitzRL. Direct-to-consumer prescription drug advertising: trends, impact, and implications: aiming drug ads at consumers means big business for drug companies, but its effect on clinical care is not yet known. Health Aff. 2000;19:110–128.
   PubMed Web of Science ®Google Scholar
• LawtonVL.Drug discovery and development E-book: technology in transition. 2nd ed.London: Elsevier; 2021.
   Google Scholar
• VentolaCL. Direct-to-consumer pharmaceutical advertising: therapeutic or toxic?Pharm Ther. 2011;36:669.
   Google Scholar
• GolichenkoM, Canadian HIV, Network AL, MerkinaiteS. Ukrainian Drugs legislation and the European Convention for the protection of human rights and fundamental freedoms. Can HIV/AIDS. 2011;8:13.
   Google Scholar
• SpurlingGK,MansfieldPR,MontgomeryBD,LexchinJ,DoustJ,OthmanN, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Med. 2010;7:e1000352.
   PubMed Web of Science ®Google Scholar
• BeltraminiRF. DTC advertising’s programmatic research and its effect on health communication. Health Commun. 2010;25:574–575.
   PubMed Web of Science ®Google Scholar
• IizukaT,JinGZ. Direct to consumer advertising and prescription choice. J Ind Econ. 2007;55:771–787.
   Google Scholar
• StremerschS. Health and marketing: the emergence of a new field of research. Int J Res Mark. 2008;25:229–233.
   Web of Science ®Google Scholar
• MainKJ,ArgoJJ,HuhmannBA. Pharmaceutical advertising in the USA: information or influence? Int J Advert. 2004;23:119–141.
   Google Scholar
• SansgiryS,SharpWT,SansgirySS. Accuracy of information on printed over-the-counter drug advertisements. Health Mark Q. 1999;17:7–18.
   PubMedGoogle Scholar
• Foxhall K. FDA may restrict acetaminophen. WebMD Heal News Retrieved Sept. 2009;3.
   Google Scholar
• HosseiniM. Consumer rights in advertising and marketing of pharmaceuticals and health products. Iran J Med Ethics Hist. 2009;3:33–42.
   Google Scholar
• PaekH-J,LeeH,PraetCLC,ChanK,ChienPM,HuhJ, et al. Pharmaceutical advertising in Korea, Japan, Hong Kong, Australia, and the US: current conditions and future directions. Health Commun Res. 2011;3:1–63.
   Google Scholar
• VlassovV,MansfieldP,LexchinJ,VlassovaA. Do drug advertisements in Russian medical journals provide essential information for safe prescribing? West J Med. 2001;174:391–395.
   PubMedGoogle Scholar
• VillanuevaP,PeiróS,LibreroJ,PereiróI. Accuracy of pharmaceutical advertisements in medical journals. Lancet. 2003;361:27–32.
   PubMed Web of Science ®Google Scholar
• DabhadeSA,DabhadeSS. Evaluation and comparison of drug advertisements published in medical journals using WHO criteria for ethical medicinal drug promotion and OPPI criteria for drug advertisements. Int J Cur Res Rev. 2021;13:174–180.
   Google Scholar
• JhaN,SapkotaY,ShankarPR. Critical evaluation of drug advertisements in a Medical College in Lalitpur, Nepal. J Multidiscip Healthc. 2020;13:717–725.
   PubMed Web of Science ®Google Scholar
• BoesenK,SimonsenAL,JørgensenKJ,GøtzschePC. Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs. Res Integr Peer Rev. 2021;6:1–11.
   PubMedGoogle Scholar
• Sam ScheeleD. The delphi method. Boston: Addison-Wesley Reading; 1975.
   Google Scholar
• SchenkerY,ArnoldRM,LondonAJ. The ethics of advertising for health care services. Am J Bioeth. 2014;14:34–43.
   PubMed Web of Science ®Google Scholar
• MeredithPA,ElliottHL. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents United States Food and Drug Administration. J Cardiovasc Pharmacol. 1994;23:26–30.
   Web of Science ®Google Scholar
• KorensteinD,KeyhaniS,MendelsonA,RossJS. Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing. PLoS ONE. 2011;6:e23336.
   PubMed Web of Science ®Google Scholar
• GreenwoodJ,RonitK. Pharmaceutical regulation in Denmark and the UK: reformulating interest representation to the transnational level. Eur J Polit Res. 1991;19:327–359.
   Web of Science ®Google Scholar
• ChanKKW. Illegal pharmaceutical advertising in China. Gaz (Leiden, Netherlands). 1996;56:73–79.
   Google Scholar
• GharibyarH,SharifY. Evaluation of pharmaceutical drug information brochures in the Emirate of Abu Dhabi (United Arab Emirates). J Pharm Health Serv Res. 2012;3:57–62.
   Google Scholar
• HandaM,VohraA,SrivastavaV. Perception of physicians towards pharmaceutical promotion in India. J Med Mark. 2013;13:82–92.
   Google Scholar
• SantiagoMG,BucherHC,NordmannAJ. Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland. BMC Med Inform Decis Mak. 2008;8:1–9.
   PubMed Web of Science ®Google Scholar
• OthmanN,VitryA,RougheadEE. Quality of pharmaceutical advertisements in medical journals: a systematic review. PLoS ONE. 2009;4:e6350.
   PubMed Web of Science ®Google Scholar
• Powrie-SmithA. European federation of pharmaceutical industries and associations. Impact. 2017;2017:38–39.
   Google Scholar
• HerxheimerA,LundborgCS,WesterholmB. Advertisements for medicines in leading medical journals in 18 countries: a 12-month survey of information content and standards. Int J Health Serv. 1993;23:161–172.
   PubMed Web of Science ®Google Scholar
• SibandaN,GavazaP,MapongaCC,MugoreL. Pharmaceutical manufacturers’ compliance with drug advertisement regulations in Zimbabwe. Am J Health Pharm. 2004;61:2678–2681.
   PubMed Web of Science ®Google Scholar
• AlamK,ShahAK,OjhaP,PalaianS,ShankarPR. Evaluation of drug promotional materials in a hospital setting in Nepal. South Med Rev. 2009;2:2.
   PubMedGoogle Scholar
• GanashreeP,BhuvanaK,SaralaN. Critical review of drug promotional literature using the World Health Organization guidelines. J Res Pharm Pract. 2016;5:162.
   PubMedGoogle Scholar
• OthmanN,VitryAI,RougheadEE. Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States. BMC Public Health. 2010;10:1–8.
   PubMed Web of Science ®Google Scholar
• TuffsA. Only 6% of drug advertising material is supported by evidence. BMJ. 2004;328:485.
   PubMedGoogle Scholar
• IslamMS,FarahSS. Misleading promotion of drugs in Bangladesh: evidence from drug promotional brochures distributed to general practitioners by the pharmaceutical companies. J Public Health (Bangkok). 2007;29:212–213.
   PubMed Web of Science ®Google Scholar